In a recent study published in the World Journal of Gastroenterology, Chen et al. demonstrate that oridonin treatment mediates inflammatory cytokine pathways, significantly reducing secretion of inflammatory cytokines by pancreatic cancer cells in vitro (Chen et al., 2014).
Researchers used three ELISA kits, available at antibodies-online, to measure the concentration of inflammatory cytokines: IL-33 ELISA kit (ABIN457022), IL-6 ELISA kit (ABIN365163), and IL-1B ELISA kit (ABIN365160) in culture supernatant from human pancreatic cancer (BxPC-3) cells.
In each case, oridonin treatment resulted in a marked decrease in the release of inflammatory cytokine molecules when compared to untreated (control) cells.
Note: For Cytokine research antibodies-online offers a number of antibody arrays.